v3.26.3
Unaudited Condensed Statements of Cash Flows - USD ($)
 8 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2026
Cash Flows from Operating Activities:    
Net income $ 4,878,813 $ 7,960,702
Adjustments to reconcile net income to net cash used in operating activities:    
Payment of general and administrative costs through IPO Promissory Note - related party 65,934
Earnings from investments held in Trust Account (5,110,483) (8,324,078)
Changes in operating assets and liabilities:    
Due from Sponsor (1,260)
Prepaid expenses (163,397) 52,474
Accounts payable and accrued expenses 5,186 13,826
Net cash used in operating activities (323,947) (298,336)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (300,000,000)
Net cash used in investing activities (300,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 294,720,000
Proceeds from sale of Private Placement Warrants 7,280,000
Due from Sponsor (2,000,000)
Payment of amounts due from Sponsor 1,705,745
Payment of offering costs (301,179) (75,000)
Net cash (used in) provided by financing activities 301,404,566 (75,000)
Net Change in Cash 1,080,619 (373,336)
Cash – Beginning of period   1,016,713
Cash – End of period 1,080,619 643,377
Non-cash investing and financing activities:    
Deferred offering costs included in accrued offering costs 376,179
Deferred offering costs paid through IPO Promissory Note - related party 228,321
Settlement of IPO Promissory Note – related party 294,255
Deferred offering costs paid by Sponsor in exchange for issuance of Class B Ordinary Shares 25,000
Deferred underwriting fee payable 12,720,000
Deferred offering costs charged to additional paid-in capital 629,500
Forfeiture of Founder Shares $ 9